Articles

• New Scientific Committee members announced
• Catalysing new thinking on the development of cancer
• OPTIMISTICC: New connection drives poor outcomes in bowel cancer
• Metabolic fingerprinting reveals link between dietary fat restriction and therapy response
• Nature Reviews Drug Discovery: addressing cancer’s grand challenges
• The power of discovery: 7 teams leading the way
• The Challenges: Professor Sir David Lane shares his thoughts on the macromolecules challenge
• AACR Cancer Discovery: Cancer Grand Challenges to fund broad, pressing research
• AACR Cancer Discovery In Focus: embarking on a new era of discovery
• The Challenges: Professor Crystal Mackall on the solid tumours in children challenge
• The Challenges: Professor René Bernards on the senescence challenge
• STORMing Cancer's Professor Don Ingber receives prestigious Wilbur Cross Medal
• The Challenges: Professor Karen Vousden on the normal phenotypes challenge
• Multidisciplinary collaboration driving new discoveries: uncovering the role of SLC7A5 in KRAS-driven colorectal cancer
• Pre-application webinar: everything you need to know about applying
• The Challenges: Professor Nic Jones on dormancy
• The Challenges: Ed Harlow shares his thoughts on the inflammation challenge
• News from the IMAXT team: Expansion Sequencing technology
• The Challenges: Professor Charlie Swanton discusses the cachexia challenge
• “We wanted to do everything we could to support them”: Nick and Annette Razey give £1m to back Cancer Grand Challenges team
• The Challenges: Professor Charlie Swanton discusses the extrachromosomal DNA challenge
• Professor Barbara Rimer on aspiring to create an inclusive world #IWD2021
• Michele Cleary on celebrating women in science #IWD2021
• Challenging the status quo and collaborating across disciplines in the IMAXT team #IWD2021
• The value of good mentorship: Amy Schade and Karen Cichowski celebrate #IWD2021
• Kimmie Ng and Candace Henley celebrate the value of the patient advocacy voice in cancer research #IWD2021
• Could the size of fat cells around DCIS breast lesions predict risk of future invasive cancer?
• The Challenges: Professor David Hunter shares his thoughts on e-cigarettes
• The microbiome: a biomarker for colorectal cancer?
• In conversation with Owen Sansom and Helen Matthews, SPECIFICANCER
• AACR Meet the Experts Session
• Inside Project Theia, the world’s first virtual reality cancer research lab – and a call for volunteers
• 7 Questions with... Jelle Wesseling, PRECISION
• Caitlin Brennan discusses the microbiome and aspirin's potential in personalised prevention
• Survival of the fittest: revealing the early stages of APC-driven colorectal cancer
• Announcing the shortlist for the Cancer Grand Challenges awards
• Questions with...Johanna Joyce, IMAXT
• Questions with...Mike Stratton, Mutographs
• A COSMIC catalogue of cancer data, with Mutographs' Ellie Dunstone
• IMAXT’s Nic Walton: uniting across disciplines to share learnings in data science
• Cindy Sears: the power of preclinical models and learnings from global health
• 7 Questions with... John Marioni, IMAXT
• Unravelling the drivers of immune evasion in head and neck cancer
• Escape from the immune system